Valuation: Medpace Holdings, Inc.

Market Cap 16.87B 15.07B 14.06B 12.77B 24.05B 1,631B 24.23B 169B 66.01B 830B 63.32B 61.95B 2,667B P/E 2026 *
34.4x
P/E 2027 * 31.5x
Enterprise Value 16.09B 14.37B 13.41B 12.18B 22.94B 1,556B 23.11B 161B 62.95B 791B 60.39B 59.08B 2,544B EV / Sales 2026 *
5.64x
EV / Sales 2027 * 5.15x
Free-Float
81.06%
Yield 2026 *
-
Yield 2027 * -
1 day-0.90%
1 week-0.05%
Current month-4.23%
1 month+1.17%
3 months+12.37%
6 months+14.82%
Current year+6.44%
1 week 587.38
Extreme 587.385
642.64
1 month 577.64
Extreme 577.64
642.64
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
9/30/26 A Sell

Chief Executive Officer

-21,966 0.0787%
9/30/26 A Exercice

Director

64 0.0002%
9/30/26 A Exercice

Director

72 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.90%-0.05%+12.58%+141.09% 16.87B
+4.16%+4.16%+49.37%+94.17% 74.68B
-13.64%-14.19%+5.09%+54.65% 58.7B
-1.82%+1.03%+3.96%+32.03% 48.36B
-7.65%-6.06%+304.44%+659.34% 43.05B
-1.18%-2.16%+27.17%+27.84% 42.48B
-4.53%-2.91%-0.78%+101.60% 41.39B
-0.11%+1.96%+9.19%+52.66% 31.29B
-1.71%-3.66%-12.20%-14.64% 23.93B
-3.26%-9.67%-39.38%+300.20% 22.22B
Average -3.00%-2.28%+35.94%+144.90% 40.3B
Weighted average by Cap. -3.13%-1.63%+44.02%+138.75%

Financials

2026 *2027 *
Net sales 2.85B 2.55B 2.38B 2.16B 4.07B 276B 4.1B 28.57B 11.16B 140B 10.71B 10.48B 451B 3.03B 2.71B 2.53B 2.3B 4.33B 293B 4.36B 30.38B 11.87B 149B 11.39B 11.14B 480B
Net income 503M 449M 419M 381M 717M 48.62B 722M 5.03B 1.97B 24.73B 1.89B 1.85B 79.49B 546M 488M 456M 414M 779M 52.86B 785M 5.47B 2.14B 26.88B 2.05B 2.01B 86.43B
Net Debt -780M -697M -650M -591M -1.11B -75.47B -1.12B -7.82B -3.05B -38.38B -2.93B -2.87B -123B -1.24B -1.11B -1.04B -942M -1.77B -120B -1.79B -12.46B -4.87B -61.19B -4.67B -4.57B -197B
Projected Income Statement - Annual - Medpace Holdings, Inc.
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
08/10/26 $597.85 -1.06% 7,521
07/10/26 $604.25 +0.22% 207,572
06/10/26 $602.90 -2.84% 219,131
05/10/26 $620.51 +3.51% 341,180
02/10/26 $599.47 +0.23% 303,678
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - Medpace Holdings, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
604.25USD
Average target price
594.54USD
Spread / Average Target
-1.61%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Medpace Holdings, Inc.
  1. Stock Market
  2. Stocks
  3. MEDP Stock